Vaxcyte, Inc. - PCVX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 8.9% | 12,974,599 | View |
| May 15, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 8.9% | 12,974,599 | View |
| May 15, 2026 | SCHEDULE 13G/A | Rajeev Shah | 8.9% | 12,974,599 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 8.7% | 12,699,089 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 11.5% | 16,575,875 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 11.4% | 16,451,061 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 11.4% | 16,451,061 | View |
| Apr 30, 2026 | SCHEDULE 13G | Vanguard Capital Management | 5.03% | 7,252,053 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 8.6% | 11,296,333 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.